Fig. 6

Dynamic changes of HCMV DNA and hcmv-miR-US25-1-3p during the treatment of anti-HCMV virus in five patients after bone marrow transplantation. a Patient No. 1 suffered with severe aplastic anemia with occurrence of viremia on the 33rd day after transplantation; b Patient No. 2 suffered with severe aplastic anemia with occurrence of viremia on 65th day after transplantation; c Patient No. 3 suffered with AML M2a with occurrence of viremia on 27th day after transplantation; d Patient No. 4 suffered with myelodysplastic syndromes with occurrence of viremia on 42nd day after transplantation; e Patient No. 5 suffered with ALM with occurrence of viremia on 33rd day after transplantation. The time of the patient underwent bone marrow transplant was taken as a starting monitor point (zero day) and the abscissa axis is based on the number of days after transplantation. The ordinates represented the levels of HCMV DNA and hcmv-miR-US25-1-3p, with blue line represented HCMV DNA level, and the red line represents hcmv-miR-US25-1-3p